Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells.
about
Roles for miRNAs in endocrine resistance in breast cancerPredicting response to preoperative chemotherapy agents by identifying drug action on modeled microRNA regulation networksDehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptorAn integrative analysis of cellular contexts, miRNAs and mRNAs reveals network clusters associated with antiestrogen-resistant breast cancer cells.Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cellsMicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.Correlative Analysis of miRNA Expression and Oncotype Dx Recurrence Score in Estrogen Receptor Positive Breast CarcinomasmiRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets.miRNAs and estrogen action.HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance.Endocrine disruptors fludioxonil and fenhexamid stimulate miR-21 expression in breast cancer cells.Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance.Antiestrogen Resistance and the Application of Systems BiologySerum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort.Endocrine resistance in breast cancer: Current status and a perspective on the roles of miRNAs (Review).Multidrug-resistant breast cancer: current perspectives.MicroRNAs and drug resistance of breast cancer: basic evidence and clinical applications.miR-221/222: promising biomarkers for breast cancer.Identification of microRNA-regulated autophagic pathways in plant lectin-induced cancer cell death.The novel role of miRNAs for tamoxifen resistance in human breast cancer.miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.Overcoming Resistance to Endocrine Therapy in Breast Cancer: New Approaches to a Nagging Problem.Regulation of miR-29b-1/a transcription and identification of target mRNAs in CHO-K1 cells.Gender and cardiovascular disease: are sex-biased microRNA networks a driving force behind heart failure with preserved ejection fraction in women?Identification of differentially expressed genes in human breast cancer cells induced by 4-hydroxyltamoxifen and elucidation of their pathophysiological relevance and mechanisms.The Unknown microRNA Expression of Male Breast Cancer. Similarities and Differences with Female Ductal Carcinoma. Their Role as Tumor Biomarker.Differential microRNA expression profiles in tamoxifen-resistant human breast cancer cell lines induced by two methods.Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cells.Identification of cancer-related miRNA-lncRNA biomarkers using a basic miRNA-lncRNA network.microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
P2860
Q26783076-726D4E3B-3E97-4B17-9F95-9148659D8D0DQ28539028-67A77CAD-0638-4581-B0E2-B5309BBE554EQ33820667-10E9C2C5-2A89-4D04-B011-844F2670D644Q34523785-AAC6DC06-4813-4EFF-AD98-9EEBA1F150AAQ34693000-4D7C5C7E-6455-4382-A645-AAF46342410FQ35128098-6958F65D-E653-427A-AFB4-36D1C860F9CBQ35749170-1B555A2D-EB1B-4402-8C76-AD76C5EFBC2DQ35881998-0C4A48F8-A5AE-4887-AC2F-ACE0F40DD073Q35912303-00A0A6E2-57DE-432D-ABA5-3477EC384E0BQ35946984-5DE0A6E6-778D-476E-A0BD-56E30240C60FQ36029524-0B1F7B76-C5E5-481B-BFD6-A959346D8C0EQ36509058-60BCB990-DF7A-4370-8F8B-4C5549EB4B79Q36589865-499F66AA-E5E9-4FC5-8913-9DC199F5CDB6Q36713946-B041497B-61C4-453A-A4D7-93AACABD2D6DQ36997902-BA157A72-81B7-425B-820D-40A5D8A034BCQ37211627-9AAD4A7F-298F-4C3D-A7B8-7E60558661E9Q37593383-098AB72C-93F5-4963-80EE-C36A2FE8182CQ38036917-2C2E8B66-6FCB-4C4E-A62A-CFBD77CE3890Q38093079-7859CD22-54B1-44B3-BFE1-6C5E5CFF0464Q38322784-E3B0C7C2-1A09-4391-AEF3-7CE8F2EEE56EQ38381678-8FAC27BB-8F1C-468A-8B53-6F8ACC507606Q38812266-2B192C96-67FB-4359-87CA-EC240A53C7E8Q42755954-DFC3388C-D9E0-40AD-BC5D-A9DA539523ADQ42775546-1745445C-5FDA-446C-B044-C7E0EAD5CDA7Q47571604-17B05CAB-CA18-4EDB-9C43-F83210B20FFCQ49412994-AD41CB8F-D303-4B92-BA8B-5AC0C1A21E38Q50292125-00F6F448-E0C0-47D3-884A-648558847F47Q50300886-D8321EA5-74FE-4536-BFF2-632C70FCA2A7Q51254914-09F899A5-0881-47E7-921B-04A5BDAFFA04Q54963939-B3DE5CBF-497A-4FEA-854D-6A950E3DF974Q57106025-6F3F2B57-8730-4726-977D-D43671D5B4BF
P2860
Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Differential expression of mic ...... LY2 human breast cancer cells.
@ast
Differential expression of mic ...... LY2 human breast cancer cells.
@en
type
label
Differential expression of mic ...... LY2 human breast cancer cells.
@ast
Differential expression of mic ...... LY2 human breast cancer cells.
@en
prefLabel
Differential expression of mic ...... LY2 human breast cancer cells.
@ast
Differential expression of mic ...... LY2 human breast cancer cells.
@en
P2093
P2860
P1433
P1476
Differential expression of mic ...... LY2 human breast cancer cells
@en
P2093
Savitri N Appana
Susmita Datta
Tissa T Manavalan
P2860
P356
10.1016/J.CANLET.2011.08.018
P407
P577
2011-09-10T00:00:00Z